-
Equasens: RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 27 JUNE 2024
Источник: Nasdaq GlobeNewswire / 05 июл 2024 11:00:00 America/Chicago
Villers-lès-Nancy, 5 July 2024 - 6:00 p.m. (CET)
PRESS RELEASE
RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED
TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING
OF 27 JUNE 2024Number of shares comprising the share capital: 15,174,125
Number of shares with voting rights: 15,031,080
Number of shares with voting rights possessed by shareholders presents or represented or having voted by mail: 13,070,268
That means a quorum of 86.95% of the 15,031,080 shares with voting rights: the Ordinary Annual General Meeting was able to deliberate.
The Ordinary Annual General Meeting was held on Thursday, 27 June 2024 at 5:30 p.m. at the Company’s headquarters and approved the separate parent company and consolidated financial statements for the 2023 financial year. The results of the votes on the resolutions proposed at this meeting by the Board of Directors were as follows:
Resolutions
Results of the votes
- RESOLUTION ONE
Resolution adopted by: - 13,068,136 votes in favour
- 0 vote against
- 2,132 abstentions
- RESOLUTION TWO
Resolution adopted by: - 12,777,518 votes in favour
- 290,512 votes against
- 2,238 abstentions
- RESOLUTION THREE
Approval of the consolidated financial statements
Resolution adopted by: - 13,068,136 votes in favour
- 0 vote against
- 2,132 abstentions
- RESOLUTION FOUR
Resolution adopted by: - 13,070,236 votes in favour
- 0 vote against
- 32 abstentions
- RESOLUTION FIVE
Resolution adopted by (*): - 13,023,724 votes in favour
- 46,492 votes against
- 32 abstentions
- RESOLUTION SIX
Resolution adopted by: - 10,650,758 votes in favour
- 2,419,478 votes against
- 32 abstentions
- RESOLUTION SEVEN
Resolution adopted by: - 13,070,236 votes in favour
- 0 vote against
- 32 abstentions
- RESOLUTION EIGHT
Resolution adopted by: - 12,189,192 votes in favour
- 881,044 votes against
- 32 abstentions
- RESOLUTION NINE
Resolution adopted by: - 13,006,839 votes in favour
- 63,397 votes against
- 32 abstentions
- RESOLUTION TEN
Resolution adopted by: - 13,070,236 votes in favour
- 0 vote against
- 32 abstentions
- RESOLUTION ELEVEN
Resolution adopted by: - 10,519,109 votes in favour
- 2,551,127 votes against
- 32 abstentions
- RESOLUTION TWELVE
Resolution adopted by: - 10,468,599 votes in favour
- 2,601,637 votes against
- 32 abstentions
- RESOLUTION THIRTEEN
Resolution adopted by: - 13,006,839 votes in favour
- 63,397 votes against
- 32 abstentions
- RESOLUTION FOURTEEN
Resolution adopted by: - 10,473,009 votes in favour
- 2,356,603 votes against
- 240,656 abstentions
- RESOLUTION FIFTEEN
Resolution adopted by: - 10,472,921 votes in favour
- 2,356,691 votes against
- 240,656 abstentions
- RESOLUTION SIXTEEN
Resolution adopted by: - 10,462,222 votes in favour
- 2,367,390 votes against
- 240,656 abstentions
- RESOLUTION SEVENTEEN
Resolution adopted by: - 12,985,338 votes in favour
- 63,397 votes against
- 21,533 abstentions
- RESOLUTION EIGHTEEN
Resolution adopted by: - 12,985,338 votes in favour
- 63,397 votes against
- 21,533 abstentions
- RESOLUTION NINETEEN
Resolution adopted by: - 10,931,253 votes in favour
- 2,139,015 votes against
- 0 abstention
- RESOLUTION TWENTY
Resolution adopted by: - 13,070,236 votes in favour
- 0 vote against
- 32 abstentions
(*) After deduction of excluded voting rights
Financial Calendar:
- Publication of H1 2024 Revenue: 2 August 2024 (after French market closure).
About Group Equasens
With more than 1,300 employees, Equasens Group is today a key player in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) in both primary and secondary care sectors.
With operations in France, Germany, Great Britain, Belgium, Ireland, Italy, and Luxembourg, Equasens Group today brings together healthcare professionals within a unique ecosystem in France and Europe benefiting people by making available the very best of technology.
Listed on Euronext Paris™ - Compartment B
Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable
Included in the Euronext Tech Leaders segment and the European Rising Tech labelEligible for the Deferred Settlement Service (“Service à Règlement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME)
ISIN: FR 0012882389 – Ticker Code: EQSGet all the news about the Equasens Group www.equasens.com and on LinkedIn
CONTACTS
Analyst and Investor Relations:
Chief Administrative and Financial Officer: Frédérique SCHMIDT
Tel. +33 (0)3 83 15 90 67 - frederique.schmidt@equasens.comMedia Relations:
FIN’EXTENSO - Isabelle APRILE
Tel. +33 (0)6 17 38 61 78 – i.aprile@finextenso.frAttachment